Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Change of Adviser

3rd Nov 2010 07:00

RNS Number : 5111V
Avia Health Informatics PLC
03 November 2010
 



3 November 2010

Avia Health Informatics Plc

 

("Avia" or the "Company")

 

New Advisers

 

Highlights

 

·; Panmure Gordon (UK) Limited appointed nominated adviser and broker

·; DLA Piper appointed legal advisers

 

Avia (AIM: AVIA), the AIM-listed developer and provider of clinical decision support systems worldwide, is pleased to announce the appointment of Panmure Gordon (UK) Limited as its nominated adviser and broker, and DLA Piper as legal advisers with immediate effect.

 

Barry Giddings, Executive Chairman of Avia, commented:

"The board believes that by these appointments Avia will be better positioned to manage its existing operations and take advantage of international opportunities as they present themselves. I am pleased to welcome Panmure Gordon and DLA Piper to the team and I hope that their considerable international experience and presence will support the Company in penetrating global markets."

 

Enquiries:

 

Avia Health Informatics Plc

Barry Giddings, Chairman

+44 (0) 1494 618 503

 

 

Panmure Gordon (UK) Limited

 

Aubrey Powell, Director Corporate Finance

Adam Pollock, Managing Director Corporate Broking

+44 (0) 20 7459 3600

 

 

Notes to editors

 

Avia is a developer and provider of clinical decision support systems worldwide. Its Odyssey family of products is for use by clinicians and non-clinicians in various environments around the world. The delivery of Odyssey can be in a static or mobile environment from a PC, laptop, tablet or mobile device.

 

Strategy

 

The primary focus of Avia's strategy is achieving global market penetration for the Company's Odyssey software products. We deliver Odyssey clinical content, training and other services via web-deployed, cloud-enabled, mobile and PC technologies. This is achieved through direct sales and the engagement of resellers and added value partners. Avia's strategy for growing its business is focused on:

·; Organic growth in the sale of the software product range

·; Working with partners and resellers to increase penetration in new markets

 

Product range

 

The Odyssey range is built on a common medical content database which has been developed over the past 15 years. Odyssey range is continually updated, tailored with question and answer sets and a user interface adapted for the particular user groups and the environment in which it is used. The range includes:

 

·; Odyssey CareAssess to support decisions made by care assistants or clinicians in the Care Home environment

·; Odyssey FaceToFacefor face to face assessments in nurse-led clinics, walk-in centres, GP-led health centres and other services

·; Odyssey FirstAssess is specifically for use in Prison/Jails and secure environments

·; Odyssey MarineAssess for use on cargo vessels travelling the globe for use by the ship's captain or master in the event of illness or injury

·; Odyssey ParaMedic to empower paramedics to make safe assessments in emergency situations

·; Odyssey PatientAssess is specifically for use within doctor's surgeries to reduce demand for same day appointments

·; Odyssey Reception is utilised by non-clinical staff to prioritise patient queues and identify potential emergencies quickly and safely

·; Odyssey SelfAssess is to allow patients to self-assess their symptoms prior to consultation with clinical services

·; Odyssey TeleAssesssupports telephone triage by nurses in out of hours services, ambulance trusts, the MoD and other services

·; Odyssey VillageAssess to support those with limited or no clinical expertise working in remote villages and locations

 

For more information on Avia please visit: www.ahi-plc.com and the Odyssey product range: www.plainhealthcare.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
APPZMMGMGZDGGZZ

Related Shares:

CTFA.L
FTSE 100 Latest
Value8,275.66
Change0.00